Publications

1. Wan R, Zhao G, Adam EA, Selim OA, Sarcon AK, Reisdorf RL, Meves A, Zhao C, Moran SL. Evaluating the Effectiveness of Commercially Available Antiadhesion Tendon Protector Sheets in Tendon Repair Surgery Versus Tendon Repair Surgery Alone: A Preclinical Model Study. J Hand Surg Am. 2024 Sep 21 Epub 2024 Sept 21
   View PubMed
2. Yu GT, Gomez PT, Prata LG, Lehman JS, Tchkonia T, Kirkland JL, Meves A, Wyles SP. Clinicopathological and cellular senescence biomarkers in chronic stalled wounds. Int J Dermatol. 2024 Sep; 63 (9):1227-1235 Epub 2024 Feb 13
   View PubMed
3. Wyles SP, Morsy M, Lehman JS, Meves A, Moran SL. Minimally invasive surgical approach to model hypertrophic scarring in the rabbit ear. Arch Dermatol Res. 2024 Jun 27; 316 (7):435 Epub 2024 June 27
   View PubMed
4. Jing FZ, Pazhava A, Todd A, Meves A, Yu WY. Statin use does not impact sentinel lymph node metastasis and recurrence in melanoma patients: an 844-patient retrospective study. Int J Dermatol 2024 Jun 12 Epub 2024 June 12
   View PubMed
5. Meves ES, Meves A. Prognostic significance of sentinel lymph node status in thin melanoma: a retrospective analysis. Int J Dermatol 2024 Apr; 63 (4):526-527 Epub 2023 Dec 27
   View PubMed
6. Shi G, Koichi N, Wan R, Wang Y, Reisdorf R, Wilson A, Huang TCT, Amadio PC, Meves A, Zhao C, Moran SL. Pentamidine-loaded gelatin decreases adhesion formation of flexor tendon. J Orthop Translat. 2024 Mar; 45:75-87 Epub 2024 Mar 13
   View PubMed
7. Xie F, Dasari S, Deschaine M, Gleue CA, Sartori-Valinotti JC, Torgerson RR, Davis MDP, Charlesworth MC, Meves A, Lehman JS. Differential proteomic expression profiles in vulvar lichen planus as compared to normal vulvar tissue, vulvar lichen sclerosus, or oral lichen planus: An exploratory study. Exp Dermatol. 2023 Sep; 32 (9):1498-1508 Epub 2023 June 15
   View PubMed
8. Berger CK, Taylor WR, Mahoney DW, Burger KN, Doering KA, Gonser AM, Cao X, Heilberger J, Gysbers BJ, Foote PH, Kottschade LA, Markovic SN, Lehman JS, Katerov VE, Allawi HT, Kisiel JB, Meves A. Plasma Methylated DNA Markers for Melanoma Surveillance. JCO Precis Oncol. 2023 Sep; 7:e2300389
   View PubMed
9. Quattrocchi E, Meves ES, Meves A. CP-GEP (Merlin) gene expression profiling: can my melanoma patient forgo sentinel lymph node biopsy? Ital J Dermatol Venerol. 2023 Aug; 158 (4):292-301
   View PubMed
10. Xie F, Morken CM, Zhang N, Pittelkow MR, Sartori Valinotti JC, Comfere NI, Meves A, Murphree DH, Mangold AR, Lehman JS, Mayo Clinic Lichen Planus Consortium. Development of the lichen planus quality of life questionnaire (LPQoL) informed by expert clinician input and patient feedback: a retrospective survey study. Arch Dermatol Res. 2023 Aug; 315 (6):1561-1569 Epub 2023 Jan 30
    View PubMed
11. Meves A, Todd A, Johnson EF. Tumor width and calculated tumor area do not outperform Breslow thickness in predicting sentinel lymph node biopsy positivity. J Am Acad Dermatol. 2023 Jul; 89 (1):188-190 Epub 2023 Mar 21
    View PubMed
12. Meves ES, Meves A. Neutrophil to lymphocyte ratio: lack of association with sentinel lymph node biopsy status and relapse-free survival in cutaneous melanoma patients. Int J Dermatol 2023 Jun; 62 (6):e329-e330 Epub 2022 Aug 11
    View PubMed
13. Mereuta OM, Abbasi M, Arturo Larco JL, Dai D, Liu Y, Arul S, Kadirvel R, Hanel RA, Yoo AJ, Almekhlafi MA, Layton KF, Delgado Almandoz JE, Kvamme P, Mendes Pereira V, Jahromi BS, Nogueira RG, Gounis MJ, Patel B, Aghaebrahim A, Sauvageau E, Bhuva P, Soomro J, Demchuk AM, Thacker IC, Kayan Y, Copelan A, Nazari P, Cantrell DR, Haussen DC, Al-Bayati AR, Mohammaden M, Pisani L, Rodrigues GM, Puri AS, Entwistle J, Meves A, Savastano L, Cloft HJ, Nimjee SM, McBane RD 2nd, Kallmes DF, Brinjikji W. Correlation of von Willebrand factor and platelets with acute ischemic stroke etiology and revascularization outcome: an immunohistochemical study. J Neurointerv Surg. 2023 May; 15 (5):488-494 Epub 2022 May 20
    View PubMed
14. Xie F, Gleue CA, Deschaine M, Dasari S, Sartori-Valinotti JC, Charlesworth MC, Meves A, Lehman JS. Differential proteomic expression in indolent versus transforming oral lichen planus. Exp Dermatol. 2023 Apr; 32 (4):502-510 Epub 2023 Jan 10
    View PubMed
15. Thao V, Dholakia R, Moriarty JP, Borah BJ, Dwarkasing J, Meves A. Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis. Int J Dermatol. 2023 Jan; 62 (1):56-61 Epub 2022 Nov 28
    View PubMed
16. Murphree DH, Puri P, Shamim H, Bezalel SA, Drage LA, Wang M, Pittelkow MR, Carter RE, Davis MDP, Bridges AG, Mangold AR, Yiannias JA, Tollefson MM, Lehman JS, Meves A, Otley CC, Sokumbi O, Hall MR, Comfere N. Deep learning for dermatologists: Part I. Fundamental concepts. J Am Acad Dermatol. 2022 Dec; 87 (6):1343-1351 Epub 2020 May 17
    View PubMed
17. Puri P, Comfere N, Drage LA, Shamim H, Bezalel SA, Pittelkow MR, Davis MDP, Wang M, Mangold AR, Tollefson MM, Lehman JS, Meves A, Yiannias JA, Otley CC, Carter RE, Sokumbi O, Hall MR, Bridges AG, Murphree DH. Deep learning for dermatologists: Part II. Current applications. J Am Acad Dermatol. 2022 Dec; 87 (6):1352-1360 Epub 2020 May 16
    View PubMed
18. Gleue CA, Xie F, Deschaine M, Dasari S, Sartori-Valinotti JC, Torgerson RR, Davis MDP, Charlesworth MC, Meves A, Lehman JS. Differential proteomic expression in indolent vulvar lichen sclerosus, transforming vulvar lichen sclerosus and normal vulvar tissue. Exp Dermatol. 2022 Dec; 31 (12):1920-1926 Epub 2022 Aug 26
    View PubMed
19. Sadurni MB, Meves A. Breslow thickness 2.0: Why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies. Mod Pathol. 2022 Nov; 35 (11):1509-1514 Epub 2022 June 02
    View PubMed
20. Xie F, Meves A, Lehman JS. The genomic and proteomic landscape in oral lichen planus versus oral squamous cell carcinoma: a scoping review. Int J Dermatol. 2022 Oct; 61 (10):1227-1236 Epub 2022 May 16
    View PubMed
21. Jakub JW, Weaver AL, Meves A. Association of tumor molecular factors with in-transit metastasis in primary cutaneous melanoma. Int J Dermatol. 2022 Sep; 61 (9):1117-1123 Epub 2022 Mar 05
    View PubMed
22. Hieken TJ, Sadurni MB, Quattrocchi E, Kobic A, Sominidi-Damodaran S, Dwarkasing JT, Meerstein-Kessel L, Bridges AG, Meves A. Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study. Int J Dermatol. 2022 Jul; 61 (7):848-854 Epub 2022 Jan 31
    View PubMed
23. Mereuta OM, Abbasi M, Fitzgerald S, Dai D, Kadirvel R, Hanel RA, Yoo AJ, Almekhlafi MA, Layton KF, Delgado Almandoz JE, Kvamme P, Mendes Pereira V, Jahromi BS, Nogueira RG, Gounis MJ, Patel B, Aghaebrahim A, Sauvageau E, Bhuva P, Soomro J, Demchuk AM, Thacker IC, Kayan Y, Copelan A, Nazari P, Cantrell DR, Haussen DC, Al-Bayati AR, Mohammaden M, Pisani L, Rodrigues GM, Puri AS, Entwistle J, Meves A, Arturo Larco JL, Savastano L, Cloft HJ, Kallmes DF, Doyle KM, Brinjikji W. Histological evaluation of acute ischemic stroke thrombi may indicate the occurrence of vessel wall injury during mechanical thrombectomy. J Neurointerv Surg. 2022 Apr; 14 (4):356-361 Epub 2021 May 11
    View PubMed
24. Xie F, Gleue CA, Deschaine M, Dasari S, Lau JS, Sartori-Valinotti JC, Meves A, Lehman JS. Whole-exome sequencing of transforming oral lichen planus reveals mutations in DNA damage repair and apoptosis pathway genes. J Oral Pathol Med. 2022 Apr; 51 (4):395-404 Epub 2022 Mar 01
    View PubMed
25. Rentroia-Pacheco B, Tjien-Fooh FJ, Quattrocchi E, Kobic A, Wever R, Bellomo D, Meves A, Hieken TJ. Clinicopathologic models predicting non-sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node? J Surg Oncol. 2022 Mar; 125 (3):516-524 Epub 2021 Nov 04
    View PubMed
26. Wang L, Wang B, Gasek NS, Zhou Y, Cohn RL, Martin DE, Zuo W, Flynn WF, Guo C, Jellison ER, Kim T, Prata LGPL, Palmer AK, Li M, Inman CL, Barber LS, Al-Naggar IMA, Zhou Y, Du W, Kshitiz Kshitiz, Kuchel GA, Meves A, Tchkonia T, Kirkland JL, Robson P, Xu M. Targeting p21(Cip1) highly expressing cells in adipose tissue alleviates insulin resistance in obesity. Cell Metab. 2022 Jan 4; 34 (1):75-89.e8 Epub 2021 Nov 22
    View PubMed
27. Wang L, Wang B, Gasek NS, Zhou Y, Cohn RL, Martin DE, Zuo W, Flynn WF, Guo C, Jellison ER, Kim T, Langhi Prata LGP, Palmer AK, Li M, Inman CL, Barber LS, Al-Naggar IMA, Zhou Y, Du W, Kshitiz Kshitiz, Kuchel GA, Meves A, Tchkonia T, Kirkland JL, Robson P, Xu M. Targeting p21(Cip1) highly expressing cells in adipose tissue alleviates insulin resistance in obesity. Cell Metab. 2022 Jan 4; 34 (1):186
    View PubMed
28. Hartono SP, Bedell VM, Alam SK, O'Gorman M, Serres M, Hall SR, Pal K, Kudgus RA, Mukherjee P, Seelig DM, Meves A, Mukhopadhyay D, Ekker SC, Hoeppner LH. Vascular Endothelial Growth Factor as an Immediate-Early Activator of Ultraviolet-Induced Skin Injury. Mayo Clin Proc. 2022 Jan; 97 (1):154-164 Epub 2021 Nov 23
    View PubMed
29. Eggermont AMM, Bellomo D, Dwarkasing J, Meerstein-Kessel L, Meves A. The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model. Eur J Cancer 2021 Nov; 157:518-519 Epub 2021 Sept 24
    View PubMed
30. Camell CD, Yousefzadeh MJ, Zhu Y, Prata LGPL, Huggins MA, Pierson M, Zhang L, O'Kelly RD, Pirtskhalava T, Xun P, Ejima K, Xue A, Tripathi U, Espindola-Netto JM, Giorgadze N, Atkinson EJ, Inman CL, Johnson KO, Cholensky SH, Carlson TW, LeBrasseur NK, Khosla S, O'Sullivan MG, Allison DB, Jameson SC, Meves A, Li M, Prakash YS, Chiarella SE, Hamilton SE, Tchkonia T, Niedernhofer LJ, Kirkland JL, Robbins PD. Senolytics reduce coronavirus-related mortality in old mice. Science. 2021 Jul 16; 373 (6552) Epub 2021 June 08
    View PubMed
31. Yousaf A, Tjien-Fooh FJ, Rentroia-Pacheco B, Quattrocchi E, Kobic A, Tempel D, Kolodney M, Meves A. Validation of CP-GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study. Int J Dermatol. 2021 Jul; 60 (7):851-856 Epub 2021 Apr 29
    View PubMed
32. Dong Z, Yeo KS, Lopez G, Zhang C, Dankert Eggum EN, Rokita JL, Ung CY, Levee TM, Her ZP, Howe CJ, Hou X, van Ree JH, Li S, He S, Tao T, Fritchie K, Torres-Mora J, Lehman JS, Meves A, Razidlo GL, Rathi KS, Weroha SJ, Look AT, van Deursen JM, Li H, Westendorf JJ, Maris JM, Zhu S. GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma. Cancer Res. 2021 Jun 01; 81(11):2995-3007. Epub 2021 Feb 18.
    View PubMed
33. Ekstein SF, Wyles SP, Moran SL, Meves A. Keloids: a review of therapeutic management. Int J Dermatol. 2021 Jun; 60 (6):661-671 Epub 2020 Sept 09
    View PubMed
34. Niewold TB, Meves A, Lehman JS, Popovic-Silwerfeldt K, Hayry A, Soderlund-Matell T, Charlesworth CM, Madden B, Lundberg IE, Wahren-Herlenius M, Svenungsson E, Oke V. Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE. Arthritis Res Ther. 2021 Apr 30; 23 (1):132
    View PubMed
35. Pietrobono S, Anichini G, Sala C, Manetti F, Almada LL, Pepe S, Carr RM, Paradise BD, Sarkaria JN, Davila JI, Tofani L, Battisti I, Arrigoni G, Ying L, Zhang C, Li H, Meves A, Fernandez-Zapico ME, Stecca B. ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL. Nat Commun. 2020 Nov 17; 11 (1):5865
    View PubMed
36. Kung FF, Arias-Mejias SM, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Weaver AL, Meves A. PD-1, PD-L1, and BIM as Predictors of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. J Invest Dermatol 2020 Nov; 140 (11):2301-2304.e3 Epub 2020 Apr 08
    View PubMed
37. Arias-Mejias SM, Quattrocchi E, Tempel D, Luna-Vargas M, Chen J, Murphree DH, Gjorgova Gjeorgjievski S, Lehman JS, Bridges AG, Dwarkasing J, Meves A. Primary cutaneous melanoma risk stratification using a clinicopathologic and gene expression model: a pilot study. Int J Dermatol 2020 Nov; 59 (11):e431-e433 Epub 2020 June 09
    View PubMed
38. Eggermont AMM, Bellomo D, Arias-Mejias SM, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Murphree DH, Pittelkow MR, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, Rentroia-Pacheco B, Wever R, van Vliet MH, Dwarkasing J, Meves A. Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model. Eur J Cancer. 2020 Nov; 140:11-18 Epub 2020 Oct 05
    View PubMed
39. Meves A, Eggermont AMM. Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling. Mayo Clin Proc Innov Qual Outcomes. 2020 Oct; 4 (5):586-587 Epub 2020 July 17
    View PubMed
40. Quattrocchi E, Sominidi-Damodaran S, Murphree DH, Meves A. beta3 integrin immunohistochemistry as a method to predict sentinel lymph node status in patients with primary cutaneous melanoma. Int J Dermatol. 2020 Oct; 59 (10):1241-1248 Epub 2020 Aug 09
    View PubMed
41. Samarelli AV, Ziegler T, Meves A, Fassler R, Bottcher RT. Rabgap1 promotes recycling of active beta1 integrins to support effective cell migration. J Cell Sci. 2020 Sep 23; 133 (18) Epub 2020 Sept 23
    View PubMed
42. Arias-Mejias SM, Warda KY, Quattrocchi E, Alonso-Quinones H, Sominidi-Damodaran S, Meves A. The role of integrins in melanoma: a review. Int J Dermatol. 2020 May; 59 (5):525-534 Epub 2020 Mar 10
    View PubMed
43. Bellomo D, Arias-Mejias SM, Ramana C, Heim JB, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Pittelkow MR, DiCaudo DJ, Pockaj BA, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, van Vliet MH, Dwarkasing J, Meves A. Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. JCO Precis Oncol. 2020; 4:319-334 Epub 2020 Apr 14
    View PubMed
44. Bellomo D, Bridges AG, Hieken TJ, Meves A. Reply to E. K. Bartlett et al and A. H. R. Varey et al. JCO Precis Oncol. 2020; 4:992-994 Epub 2020 Sept 03
    View PubMed
45. Victorelli S, Lagnado A, Halim J, Moore W, Talbot D, Barrett K, Chapman J, Birch J, Ogrodnik M, Meves A, Pawlikowski JS, Jurk D, Adams PD, van Heemst D, Beekman M, Slagboom PE, Gunn DA, Passos JF. Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction. EMBO J. 2019 Dec 2; 38 (23):e101982 Epub 2019 Oct 21
    View PubMed
46. Lehman JS, Dasari S, Damodaran SS, El-Azhary RA, Gibson LE, Hashmi SK, Hogan WJ, Kenderian SJ, Patnaik MS, Litzow MR, Lazarus HM, Meves A. Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin. Clin Exp Dermatol. 2019 Jun; 44 (4):e81-e88 Epub 2018 Oct 02
    View PubMed
47. Kim GY, Schmelkin LA, Davis MD, El-Azhary RA, Wieland CN, Leise MD, Meves A, Lehman JS. Clinical and histopathologic manifestations of solid organ transplantation-associated graft-versus-host disease involving the skin: A single-center retrospective study. J Cutan Pathol. 2018 Nov; 45 (11):817-823 Epub 2018 Aug 19
    View PubMed
48. Kim GY, Schmelkin LA, Davis MDP, El-Azhary RA, Farrell AM, Meves A, Lehman JS. Dermatologic manifestations of solid organ transplantation-associated graft-versus-host disease: A systematic review. J Am Acad Dermatol. 2018 Jun; 78 (6):1097-1101.e1 Epub 2017 Dec 27
    View PubMed
49. Heim JB, McDonald CA, Wyles SP, Sominidi-Damodaran S, Squirewell EJ, Li M, Motsonelidze C, Bottcher RT, van Deursen J, Meves A. FAK auto-phosphorylation site tyrosine 397 is required for development but dispensable for normal skin homeostasis. PLoS One. 2018; 13 (7):e0200558 Epub 2018 July 12
    View PubMed
50. Lehman JS, Hashmi SK, Lazarus HM, El-Azhary RA, Gibson LE, Hogan WJ, Litzow MR, Patnaik MS, Buadi F, Lacy MQ, Dasari S, Vanderboom P, Meves A. Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods. J Cutan Pathol. 2017 Dec; 44 (12):1087-1091 Epub 2017 Sept 14
    View PubMed
51. Zhu S, Zhang X, Weichert-Leahey N, Dong Z, Zhang C, Lopez G, Tao T, He S, Wood AC, Oldridge D, Ung CY, van Ree JH, Khan A, Salazar BM, Lummertz da Rocha E, Zimmerman MW, Guo F, Cao H, Hou X, Weroha SJ, Perez-Atayde AR, Neuberg DS, Meves A, McNiven MA, van Deursen JM, Li H, Maris JM, Look AT. LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis. Cancer Cell. 2017 Sep 11; 32(3):310-323.e5. Epub 2017 Aug 31.
    View PubMed
52. Sominidi-Damodaran S, Guo R, Meves A, Bridges AG. Expanded traditional melanoma FISH testing versus CAP-QPCR to identify high-risk melanocytic lesions. Int J Dermatol 2017 Sep; 56 (9):e182-e184 Epub 2017 Mar 20
    View PubMed
53. Laniosz V, Onajin O, Sominidi-Damodaran S, Meves A, Gibson LE, Baum CL. Natural killer cell response is a predictor of good outcome in MCPyV+ Merkel cell carcinoma: A case series of 23 patients. J Am Acad Dermatol 2017 Jul; 77 (1):31-32 Epub 2017 Mar 25
    View PubMed
54. Heim JB, Squirewell EJ, Neu A, Zocher G, Sominidi-Damodaran S, Wyles SP, Nikolova E, Behrendt N, Saunte DM, Lock-Andersen J, Gaonkar KS, Yan H, Sarkaria JN, Krendel M, van Deursen J, Sprangers R, Stehle T, Bottcher RT, Lee JH, Ordog T, Meves A. Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix. Proc Natl Acad Sci U S A. 2017 Apr 11; 114 (15):3933-3938 Epub 2017 Mar 27
    View PubMed
55. Zhang X, Dong Z, Zhang C, Ung CY, He S, Tao T, Oliveira AM, Meves A, Ji B, Look AT, Li H, Neel BG, Zhu S. Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation. Cell Rep. 2017 Mar 21; 18 (12):2932-2942
    View PubMed
56. Sominidi-Damodaran S, Meves A. Cell adhesion phenotyping by quantitative polymerase chain reaction in melanoma: Clarifying misconceptions. J Am Acad Dermatol 2017 Jan; 76 (1):e23
    View PubMed
57. Barrick BJ, Ida CM, Laniosz V, Jentoft ME, Sominidi-Damodaran S, Wieland CN, Meves A, Lehman JS. Bullous Pemphigoid, Neurodegenerative Disease, and Hippocampal BP180 Expression: A Retrospective Postmortem Neuropathologic Study. J Invest Dermatol 2016 Oct; 136 (10):2090-2092 Epub 2016 June 24
    View PubMed
58. Sominidi-Damodaran S, Pittelkow MR, Meves A. Gene Expression Profiling in Cutaneous Melanoma: Caveats for Clinicians. Mayo Clin Proc 2016 Aug; 91 (8):1147-8
    View PubMed
59. Graham RP, Terracciano LM, Meves A, Vanderboom PM, Dasari S, Yeh MM, Torbenson MS, Cruise MW. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss. Mod Pathol. 2016 Jun; 29 (6):607-15 Epub 2016 Mar 25
    View PubMed
60. Meves A, Nikolova E, Heim JB, Squirewell EJ, Cappel MA, Pittelkow MR, Otley CC, Behrendt N, Saunte DM, Lock-Andersen J, Schenck LA, Weaver AL, Suman VJ. Tumor Cell Adhesion As a Risk Factor for Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. J Clin Oncol. 2015 Aug 10; 33 (23):2509-15 Epub 2015 July 06
    View PubMed
61. Tseng HY, Thorausch N, Ziegler T, Meves A, Fassler R, Bottcher RT. Sorting nexin 31 binds multiple beta integrin cytoplasmic domains and regulates beta1 integrin surface levels and stability. J Mol Biol. 2014 Sep 9; 426 (18):3180-3194 Epub 2014 July 11
    View PubMed
62. Meves A, Stremmel C, Bottcher RT, Fassler R. beta1 integrins with individually disrupted cytoplasmic NPxY motifs are embryonic lethal but partially active in the epidermis. J Invest Dermatol. 2013 Dec; 133 (12):2722-2731 Epub 2013 May 23
    View PubMed
63. Zanivan S, Meves A, Behrendt K, Schoof EM, Neilson LJ, Cox J, Tang HR, Kalna G, van Ree JH, van Deursen JM, Trempus CS, Machesky LM, Linding R, Wickstrom SA, Fassler R, Mann M. In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis. Cell Rep. 2013 Feb 21; 3(2):552-66. Epub 2013 Jan 31.
    View PubMed
64. Mathew S, Lu Z, Palamuttam RJ, Mernaugh G, Hadziselimovic A, Chen J, Bulus N, Gewin LS, Voehler M, Meves A, Ballestrem C, Fassler R, Pozzi A, Sanders CR, Zent R. beta1 integrin NPXY motifs regulate kidney collecting-duct development and maintenance by induced-fit interactions with cytosolic proteins. Mol Cell Biol. 2012 Oct; 32(20):4080-91. Epub 2012 Aug 06.
    View PubMed
65. Bottcher RT, Stremmel C, Meves A, Meyer H, Widmaier M, Tseng HY, Fassler R. Sorting nexin 17 prevents lysosomal degradation of beta1 integrins by binding to the beta1-integrin tail. Nat Cell Biol. 2012 Jun; 14(6):584-92. Epub 2012 May 06.
    View PubMed
66. Meves A, Geiger T, Zanivan S, DiGiovanni J, Mann M, Fassler R. Beta1 integrin cytoplasmic tyrosines promote skin tumorigenesis independent of their phosphorylation. Proc Natl Acad Sci U S A. 2011 Sep 13; 108(37):15213-8. Epub 2011 Aug 29.
    View PubMed
67. Meves A, Stremmel C, Gottschalk K, Fassler R. The Kindlin protein family: new members to the club of focal adhesion proteins. Trends Cell Biol. 2009 Oct; 19(10):504-13. Epub 2009 Sep 18.
    View PubMed
68. Albrecht J, Meves A, Bigby M. A survey of case reports and case series of therapeutic interventions in the Archives of Dermatology. Int J Dermatol. 2009 Jun; 48(6):592-7.
    View PubMed
69. Brewer JD, Meves A, Bostwick JM, Hamacher KL, Pittelkow MR. Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol. 2008 Sep; 59(3):483-7. Epub 2008 May 07.
    View PubMed
70. Brewer JD, Hundley MD, Meves A, Hargreaves J, McEvoy MT, Pittelkow MR. Staphylococcal scalded skin syndrome and toxic shock syndrome after tooth extraction. J Am Acad Dermatol. 2008 Aug; 59(2):342-6. Epub 2008 May 15.
    View PubMed
71. Meves A, el-Azhary RA, Talwalkar JA, Moore SB, Brewer JD, Motsonelidze C, McNallan KT, Reed AM, Rosen CB. Acute graft-versus-host disease after liver transplantation diagnosed by fluorescent in situ hybridization testing of skin biopsy specimens. J Am Acad Dermatol. 2006 Oct; 55(4):642-6.
    View PubMed
72. Meves A, Repacholi MH. Does ultraviolet radiation affect vaccination efficacy? Int J Dermatol. 2006 Sep; 45(9):1019-24.
    View PubMed
73. Albrecht J, Meves A, Bigby M. Case reports and case series from Lancet had significant impact on medical literature. J Clin Epidemiol. 2005 Dec; 58(12):1227-32. Epub 2005 Sep 12.
    View PubMed
74. Peus D, Beyerle A, Vasa M, Pott M, Meves A, Pittelkow MR. Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation. Exp Dermatol. 2004 Feb; 13 (2):78-85
    View PubMed
75. Meves A, Repacholi MH, Rehfuess EA. Promoting safe and effective sun protection strategies. J Am Acad Dermatol 2003 Dec; 49 (6):1203-4
    View PubMed
76. Meves A, Repacholi MH, Rehfuess EA. Global Solar UV Index: a physician's tool for fighting the skin cancer epidemic. Int J Dermatol. 2003 Oct; 42(10):846-9.
    View PubMed
77. Meves A, Stock SN, Beyerle A, Pittelkow MR, Peus D. Vitamin C derivative ascorbyl palmitate promotes ultraviolet-B-induced lipid peroxidation and cytotoxicity in keratinocytes. J Invest Dermatol. 2002 Nov; 119 (5):1103-8
    View PubMed
78. Meves A, Peus D, Pittelkow MR. Okadaic acid-induced EGF receptor and MAP kinase activation does not require reactive oxygen species in primary keratinocytes. Arch Dermatol Res. 2002 Jul; 294 (5):243-5 Epub 2002 June 13
    View PubMed
79. Meves A, Stock SN, Beyerle A, Pittelkow MR, Peus D. H(2)O(2) mediates oxidative stress-induced epidermal growth factor receptor phosphorylation. Toxicol Lett. 2001 Jul 6; 122 (3):205-14
    View PubMed
80. Peus D, Meves A, Pott M, Beyerle A, Pittelkow MR. Vitamin E analog modulates UVB-induced signaling pathway activation and enhances cell survival. Free Radic Biol Med. 2001 Feb 15; 30 (4):425-32
    View PubMed
81. Peus D, Vasa RA, Meves A, Beyerle A, Pittelkow MR. UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem Photobiol. 2000 Jul; 72 (1):135-40
    View PubMed
82. Peus D, Beyerle A, Rittner HL, Pott M, Meves A, Weyand C, Pittelkow MR. Anti-psoriatic drug anthralin activates JNK via lipid peroxidation: mononuclear cells are more sensitive than keratinocytes. J Invest Dermatol. 2000 Apr; 114 (4):688-92
    View PubMed
83. Peus D, Meves A, Vasa RA, Beyerle A, O'Brien T, Pittelkow MR. H2O2 is required for UVB-induced EGF receptor and downstream signaling pathway activation. Free Radic Biol Med. 1999 Dec; 27 (11-12):1197-202
    View PubMed
84. Peus D, Vasa RA, Beyerle A, Meves A, Krautmacher C, Pittelkow MR. UVB activates ERK1/2 and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. J Invest Dermatol. 1999 May; 112 (5):751-6
    View PubMed
85. Peus D, Vasa RA, Meves A, Pott M, Beyerle A, Squillace K, Pittelkow MR. H2O2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol. 1998 Jun; 110 (6):966-71
    View PubMed